Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Dental and Oral Health
Study Phase : Undisclosed
Sponsor : University of Aarhus
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of Enzyme-containing Lozenge on Dental Biofilm Formation, Composition and Functionality
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
November 21, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Dental and Oral Health
Highest Development Status : Undisclosed
Sponsor : University of Aarhus
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Undisclosed
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : Analyze & Realize
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
October 30, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : Analyze & Realize
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Limosilactobacillus Reuteri
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Undisclosed
Recipient : University College Cork
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
July 12, 2023
Lead Product(s) : Limosilactobacillus Reuteri
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Undisclosed
Recipient : University College Cork
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Bacillus Velezensis DSM 33864
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Estimates OY
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
November 04, 2022
Lead Product(s) : Bacillus Velezensis DSM 33864
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Estimates OY
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Undisclosed
Therapeutic Area : Dental and Oral Health
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of Enzymes on Dental Biofilm Accumulation
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
October 14, 2022
Lead Product(s) : Undisclosed
Therapeutic Area : Dental and Oral Health
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lactobacillus Plantarum DSM 33464
Therapeutic Area : Pharmacology/Toxicology
Study Phase : Undisclosed
Sponsor : Universidad Iberoamericana A.C., Mexico | Linus Biotechnology Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of Lactobacillus Plantarum DSM 33464 on Blood Lead Levels in Young Women of Child-bearing Age
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
August 18, 2022
Lead Product(s) : Lactobacillus Plantarum DSM 33464
Therapeutic Area : Pharmacology/Toxicology
Highest Development Status : Undisclosed
Sponsor : Universidad Iberoamericana A.C., Mexico | Linus Biotechnology Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Polyphenol Oxidase
Therapeutic Area : Dental and Oral Health
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
June 10, 2022
Lead Product(s) : Polyphenol Oxidase
Therapeutic Area : Dental and Oral Health
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Enzyme
Therapeutic Area : Dental and Oral Health
Study Phase : Undisclosed
Sponsor : University of Aarhus
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of an Enzyme-containing Lozenge on Dental Biofilm in Healthy Individuals.
Details : Undisclosed
Product Name : Undisclosed
Product Type : Enzyme
Upfront Cash : Inapplicable
October 07, 2021
Lead Product(s) : Enzyme
Therapeutic Area : Dental and Oral Health
Highest Development Status : Undisclosed
Sponsor : University of Aarhus
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lactobacillus Plantarum DSM 33464
Therapeutic Area : Pharmacology/Toxicology
Study Phase : Undisclosed
Sponsor : Beijing Children's Hospital | Baoding Children's Hospital | Xuzhou Children Hospital | Chengdu Women's and Children's Central Hospital | Children's Hospital of Heibei Province | Beijing Clinical Service Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
May 18, 2021
Lead Product(s) : Lactobacillus Plantarum DSM 33464
Therapeutic Area : Pharmacology/Toxicology
Highest Development Status : Undisclosed
Sponsor : Beijing Children's Hospital | Baoding Children's Hospital | Xuzhou Children Hospital | Chengdu Women's and Children's Central Hospital | Children's Hospital of Heibei Province | Beijing Clinical Service Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : NZ-GHMH-01
Therapeutic Area : Endocrinology
Study Phase : Undisclosed
Sponsor : Biofortis Mérieux Nutriscience
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
February 23, 2021
Lead Product(s) : NZ-GHMH-01
Therapeutic Area : Endocrinology
Highest Development Status : Undisclosed
Sponsor : Biofortis Mérieux Nutriscience
Deal Size : Inapplicable
Deal Type : Inapplicable